Normand Blais

Apr 29, 2024 | cmaj.ca | William Phillips |Natasha Leighl |Normand Blais |Paul Wheatley-Price

KEY POINTSTargeted cancer therapies are a group of oral medications directed at tumours harbouring specific driver mutations that occur in a subset of patients with cancer. Around one-third to one-half of patients with advanced non–small cell lung carcinoma may harbour an actionable mutation, which can be identified from molecular analysis of a biopsy or surgical specimen.